Hetlioz LQ
Active substance: tasimelteon
SUSPENSION · TASIMELTEON 4 mg/mL
United StatesActive
Marketing holder: Vanda Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- TASIMELTEON · 4 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-18be-7e47-a269-36bf3c53630d,01a1208e-fde3-7a6a-adf4-7714b09a3bac,01a12094-8f54-7322-9ac7-29bbbea67f78,01a12096-7a4d-7234-bc21-0bc6714342e4,01a1209d-5343-7183-8e00-eb0e351b4c5d;count=5 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 43068-304
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 43068-304 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43068-304 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43068-304 · Verified 2026-10-09 · open in source